Compare Inovio Pharmaceuticals Inc (INO) vs Altria Group Inc (MO) Price & Performance

Inovio Pharmaceuticals IncTrade

Altria Group IncTrade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Altria Group Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Altria Group Inc trades at $65.04 (market cap $108.58B). The key difference: Altria Group Inc is far larger — about 1382.3× Inovio Pharmaceuticals Inc's market cap, and Altria Group Inc pays a 6.52% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

	INO	MO
Market Cap	$78.55M	$108.58B
Sector	Health	Consumer Staples
52-Week High	$2.87	$74.92
52-Week Low	$0.66	$54.72
Enterprise Value	$49.56M	$130.79B
Dividend Yield	—	6.52%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INO

View details →

Invesco's PEY ETF outperforms with a dividend-growth filter, offering higher returns and reliable income.24/7 Wall Street · 19 hours agoBullish Altria offers 6.3% yield with 60 years of dividend growth, trading at a low valuation amid regulatory risks.Seeking Alpha · 4 days agoBullish View details →

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).